Webinars

The webinar was hosted via Zoom platform on 9th of December (17.00-18.00 CET, 11.00-12.00 EST, and 05.00-06.00 NZST). The discussion was led by Ziya Erdem (Environmental Engineer Consultant, USA), Ali Seyfoddin (Senior Lecturer, Auckland University of Technology, New Zealand) and Jan Zorgdrager (Principal Consultant, ProPharma Group, the Netherlands) on the topic of medicinal cannabis.

Cannabinoids have been shown beneficial for a range of clinical conditions, including pain, inflammation, epilepsy, sleep disorders, the symptoms of multiple sclerosis, anorexia, schizophrenia and other conditions. The development of cannabinoid based drugs requires well-controlled clinical trials to be carried out in order to objectively establish therapeutic efficacy, dose ranges and safety. The low oral bioavailability of cannabinoids has led to feasible methods of administration, such as the transdermal route, intranasal administration and transmucosal adsorption, being proposed. The highly lipophilic nature of cannabinoids means that they are seen as suitable candidates for advanced nanosized drug delivery systems, which can be applied via a range of routes. Nanotechnology-based drug delivery strategies have flourished in several therapeutic fields in recent years and numerous drugs have reached the market. It is rapidly growing field in Canada, USA, Australia and Europe. 

During this webinar, we will be focusing on the worldwide situation, scientific research, production challenges, applications, benefits and future perspective. 

Webinar recording: https://vimeo.com/378737677

We hope you will enjoy it!